Indefinite Delivery Contract SPE2DX15D9239

This is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $499,999,999, covers the supply of a broad range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The contract enables the DLA to issue firm fixed-price delivery orders for pharmaceutical and medical items across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. Recent delivery orders have included supplies of products like Xolair, Trikafta, Keytruda, Botox, Nucala, and other specialized medications. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards. The period of performance extends through November 2026, ensuring the continuous availability of critical pharmaceutical and medical supplies to the Department of Defense.